Meta-markers for the differential diagnosis of lung cancer and lung disease
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 148, 36-43
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health & Welfare (HI13C-2098-030013)
- National Research Foundation of Korea (2014M3A9D5A01073598)
- Korean Foundation for Cancer Research (CB2011-02-01)
This publication has 38 references indexed in Scilit:
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Cancer Biomarkers: Can We Turn Recent Failures into Success?JNCI: Journal of the National Cancer Institute, 2010
- Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein AtlasMolecular & Cellular Proteomics, 2010
- Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatinBMC Cancer, 2010
- Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2009
- Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human PlasmaMolecular & Cellular Proteomics, 2009
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasmaNature Biotechnology, 2009
- Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish populationBMC Cancer, 2007
- The Solitary Pulmonary NoduleNew England Journal of Medicine, 2003
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999